Loading...

Home
ETF
IPHA

IPHA

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

IPHA News

GT Biopharma Enters Clinical Trials with Three Drugs

Jun 02 2026Newsfilter

Innate Pharma Announces AGM Voting Results

May 22 2026Newsfilter

Innate Pharma to Participate in 2026 Investor Meetings

May 19 2026Newsfilter

Innate Pharma to Hold Investor Meetings in New York

May 19 2026Yahoo Finance

GT Biopharma Doses First Patient in GTB-5550 Clinical Trial

May 18 2026Newsfilter

Innate Pharma Reports Q1 2026 Financial Results

May 13 2026seekingalpha

Innate Pharma Reports Clinical Progress and Financial Update

May 13 2026Newsfilter

Innate Pharma Releases Share and Voting Rights Information

May 12 2026Newsfilter

Innate Pharma to Host Q1 2026 Business Update Call

May 06 2026Newsfilter

Innate Pharma to Participate in Investor Meetings

Apr 23 2026Newsfilter

Innate Pharma to Participate in Investor Meetings

Apr 23 2026Yahoo Finance

Innate Pharma Presents MATISSE Phase 2 Study Results

Apr 17 2026Yahoo Finance

Innate Pharma to Hold 2026 Annual General Meeting

Apr 13 2026Newsfilter

Innate Pharma Discloses Share and Voting Rights Information

Apr 13 2026Newsfilter

Innate Pharma to Present at AACR Oncology Event

Apr 08 2026Newsfilter

Innate Pharma to Participate in Investor Meetings

Apr 03 2026Newsfilter